Member Info for guygad

I've been away from the board for a month or more, but it looks like not much has changed. I'm not in the stock at present (booked profits long ago) so i've no bias either way. That noted, there seems to be zero people contributing actual considered argument or research to the dialog.

Part of the appeal of this company is the ease with which investors can actually track the business of the company--ad placing in games that have committed to Bidstack.

Has anyone here taken the time to download the apps, fire up a proxy, and identify the number and diversity of in game ads and thereby try to figure out whether the company is gonna hit its numbers?

Despatch of cheques and CREST accounts credited in respect of proceeds from the redemption of the B Shares: 20 October 2021

you fellas have any sense why, or is another case of loose lips?

You fellas have any insight into why the rise today?

My memory is that the dividend is to be paid today. Do you fellas have any insight on how this is done--deposit direct to the investing account or mailed cheque?

Many thanks in hope.

Any of you lot a member of the sharepickers investment club--I'm curious if JW has provided any insight into the name, this afternoon?

you fellas uneasy about the volume of new shares, and the dilution, coming to market from the exercise of warrants? (I'm gonna take a poke at the accounting for this later, but would be interested in any sense of what's going on.)

Suspect it would be pink sheets only, and prob not worth the headache.

Maybe I'm too tired after a long week, but the Vadim Alexandre pitch felt a little short on detail. Didn't help that JW was unconvinced though, to be honest, that might be a good sign. In any case, absent any news, the stock will continue to tread water.

Have you fellas seen any research reports on 4d? Any sense of the numbers expected with the next release of results?

Mucho thanks in hope

Not to get punchy, but how could this matter--HEMO trades (av) 12m shares a day and no one is making a decision to buy/ sell the thing based on the LSE buy/ sell data presentation? That aside, I hope all is well with your day.

Bugger.... didn't address the issue of class B shares and subsequent cash redemption. This entirely a function of efficient distribution from a tax pov.

A couple of notes:
The statement by management in the RNS, noting that the share price will decline by 45p is entirely logical and has nothing to do with encouraging a stock sale--if a corporation is worth £1.40 and disperses (to shareholders) £0.45, the value of the corp will be reduced by £0.45. To the extent that the language of the RNS can be parsed, it's a positive--management being up front about the near term future. Trading, thereafter, will be a function of the performance of the company--cash flow, etc.--and the wider stock market. In other words, there's no free lunch.

That noted, you might have a tax implication of receiving the dividend --my memory is that there is a £2,000 threshold for dividend income, so if your total annual dividend income exceeds £2k, you'll be taxed on the excess. Of course, if you sell the stock at a profit, there might be a tax event (capital gains?).

The decision to hold the stock is entirely a personal decision based on risk profile, income needs, other portfolio concerns, etc. I hold this as both a cash flow and growth story, but really like the management and the space in which they operate and this allows me to stress free sleep.

(Hope the above isn't too patronizing/ simplistic.)

Looks like they've run a BS scrape and found net debt is £30.7m. This is a legit number but includes lease liabilities (of £29.16k) which is paid down through normal operating activities rather than any EDIT number. In other words, its almost an operating cost. Similarly, the jump in the confidential invoice discounting facility is the result of advanced supplier payments (increased freight rates, brexit relataed charges, etc.)--a function of increased working capital.

My point is not that these numbers can be ignored. Rather, they're not the black mark that would be implied by a simple reading of bottom line net debt.

Many thanks for this. An interesting read

Have you fellas seen any broker notes, etc., on the results—someone other than proactive investor must be following the name?

Fully endorse

Go with your gut is a recipe for the poor house, regardless of the stock. Do some research and measure the risk-reward.

I'd be as concerned about the options granted to employees and the advisory committee that will amount to 8.5% of shares outstanding--in the RNS 27 July 2021, 32,703,334 already granted and plans for another 5% of shares outstanding under the long term incentive plan. The grant of options is entirely normal for a company, the prob lies in the recycling of options for not reaching targets.... if a fella fails to do his job, the company simply swaps them out for another set of options, thereby shoring the power of the existing management and board.

Results look pretty good to me. I've taken a half position this afternoon and will take more if it takes another leg down.